IRIS
Di Lorenzo, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.086
NA - Nord America 3.340
SA - Sud America 1.461
EU - Europa 642
AF - Africa 226
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.762
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.038
SG - Singapore 1.397
BR - Brasile 1.046
CN - Cina 721
HK - Hong Kong 555
BD - Bangladesh 533
IT - Italia 359
VN - Vietnam 240
MX - Messico 156
IN - India 129
AR - Argentina 123
CA - Canada 80
IQ - Iraq 76
EC - Ecuador 70
TR - Turchia 66
CO - Colombia 63
ID - Indonesia 62
VE - Venezuela 55
SA - Arabia Saudita 47
ZA - Sudafrica 47
GB - Regno Unito 44
PK - Pakistan 41
PH - Filippine 39
RU - Federazione Russa 39
MA - Marocco 37
PY - Paraguay 31
TN - Tunisia 30
DE - Germania 29
CL - Cile 28
MY - Malesia 27
UA - Ucraina 27
UZ - Uzbekistan 27
FR - Francia 26
NL - Olanda 24
EG - Egitto 23
KE - Kenya 21
ES - Italia 19
AE - Emirati Arabi Uniti 17
BO - Bolivia 16
ET - Etiopia 15
JO - Giordania 14
LB - Libano 13
PE - Perù 13
UY - Uruguay 13
DZ - Algeria 12
JM - Giamaica 11
OM - Oman 11
CR - Costa Rica 9
NP - Nepal 9
AL - Albania 8
AZ - Azerbaigian 8
KG - Kirghizistan 8
RS - Serbia 8
TH - Thailandia 8
CH - Svizzera 7
LY - Libia 7
KZ - Kazakistan 6
PS - Palestinian Territory 6
PT - Portogallo 6
RO - Romania 6
BB - Barbados 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
GE - Georgia 5
NI - Nicaragua 5
PA - Panama 5
SN - Senegal 5
TT - Trinidad e Tobago 5
AO - Angola 4
AU - Australia 4
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BS - Bahamas 4
CM - Camerun 4
HN - Honduras 4
HU - Ungheria 4
NG - Nigeria 4
SV - El Salvador 4
CZ - Repubblica Ceca 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
PL - Polonia 3
AT - Austria 2
BE - Belgio 2
CI - Costa d'Avorio 2
FI - Finlandia 2
HT - Haiti 2
KR - Corea 2
LI - Liechtenstein 2
ML - Mali 2
SC - Seychelles 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BG - Bulgaria 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
Totale 9.729
Salva come PNG Salva come JPEG
Città #
San Jose 1.940
Singapore 818
Hong Kong 533
Ashburn 371
Beijing 343
Mexico City 125
Ho Chi Minh City 98
São Paulo 74
Santa Clara 72
New York 66
Rome 54
Hanoi 52
Naples 38
Milan 33
Los Angeles 31
Rio de Janeiro 31
Baghdad 30
Tashkent 25
Quito 23
Belo Horizonte 22
Brasília 22
Lahore 22
Buffalo 21
Caracas 20
Haiphong 18
Jeddah 18
Toronto 18
Chicago 17
Nairobi 17
Dallas 16
Istanbul 16
Johannesburg 16
Santiago 16
Campinas 15
Curitiba 15
Guayaquil 15
Medellín 15
Salvador 14
Addis Ababa 13
Amman 13
Dhaka 13
Asunción 12
Buenos Aires 12
Kuala Lumpur 12
London 11
Montevideo 11
Riyadh 11
Bogotá 10
Bologna 10
Cape Town 10
Casablanca 10
Dammam 10
Jakarta 10
Palermo 10
Porto Alegre 10
Santo André 10
Cairo 9
Erbil 9
Goiânia 9
Muscat 9
San José 9
Sorocaba 9
Tunis 9
Atlanta 8
Bari 8
Charlotte 8
Hyderabad 8
La Paz 8
New Delhi 8
Philadelphia 8
Ribeirão Preto 8
Uberlândia 8
Baku 7
Boardman 7
Delhi 7
Fortaleza 7
João Pessoa 7
Lima 7
Manaus 7
Cali 6
Contagem 6
Córdoba 6
Dubai 6
Guarulhos 6
Joinville 6
Karbala 6
Kingston 6
Maringá 6
Mauá 6
Montreal 6
Mumbai 6
Rabat 6
Shanghai 6
São Bernardo do Campo 6
Tirana 6
Turin 6
Vancouver 6
Adana 5
Agadir 5
Barquisimeto 5
Totale 5.595
Salva come PNG Salva come JPEG
Nome #
Synergistic Combination of Quercetin and Mafosfamide in the Treatment of Bladder Cancer Cells 98
Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: A phase I clinical trial 87
It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature 86
Vesicourethral anastomosis during radical retropubic prostatectomy: Does the number of sutures matter? 83
The use of tamsulosin in the medical treatment of ureteral calculi: Where do we stand? 78
Gemcitabine Versus Bacille Calmette-Guerin After Initial Bacille Calmette-Guerin Failure in Non-Muscle-Invasive Bladder Cancer A Multicenter Prospective Randomized Trial 75
Effect of baseline characteristics on cabazitaxel treatment duration in patients with metastatic castration-resistant prostate cancer (mCRPC): a post hoc analysis of the compassionate use (CUP)/expanded access programs (EAP) and CAPRISTANA registry 72
Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients 68
Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis 66
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study 63
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 62
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2-10 ng/ml 60
Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study 60
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients 57
A case of renal melanoma metastasis: Description of clinico-pathological features 56
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis 54
Imatinib mesylate in thymic epithelial malignancies 52
Multicenter clinical trial of the efficacy and safety of rokitamycin in ENT infections 52
Management of AIDS-related Kaposi's sarcoma 52
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 51
Role of pegylated lyposomal doxorubicin (PLD) in systemic Kaposi's sarcoma: a systematic review 50
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 49
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 48
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers 48
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: A retrospective Italian survey 48
Evaluation of Directed Graph-Mapping in Complex Atrial Tachycardias 47
Prostate Cancer Detection in the "Grey Area" of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun's Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3 44
Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs) 44
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 42
Outcomes associated with first-line PD-1 and PD-L1 inhibitors vs. sunitinib in patients with renal cell cancer with sarcomatoid features: a systematic review and meta-analysis 42
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study 42
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis 41
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario 41
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma 40
Development and Validation of the PREVESMED Questionnaire: A Comprehensive Tool for Assessing Adherence to a Mediterranean Lifestyle 40
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 39
The Impact of Flavonoid Supplementation on Serum Oxidative Stress Levels Measured via D-ROMs Test in the General Population: The PREVES-FLAVON Retrospective Observational Study 39
Clinical characteristics of metastatic prostate cancer patients infected with COVID-19 in South Italy 39
First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry 39
Immunotherapy for the treatment of prostate cancer 38
An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples 38
Update on classic Kaposi sarcoma therapy: New look at an old disease 37
Validation of Psychometric Tools for Assessing Fatigue, Mood, and Sleep Quality: Application in the PREVES-STOP Study. 37
Contralateral prophylactic mastectomy in male breast cancer: Where do we stand 37
Predictors of Residual T1 High Grade on Re- Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer 36
Impact of Dietary Supplements on Clinical Outcomes and 2 Quality of Life in Patients with Breast Cancer: A Systematic Review 36
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 35
The evolving systemic treatment landscape for patients with advanced prostate cancer 35
Medical expulsive treatment of distal-ureteral stones using tamsulosin: A single-center experience 35
Adrenalectomy: defining its role in the surgical treatment of renal cell carcinoma. 34
Focus on localized laryngeal amyloidosis: Management of five cases 34
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 33
Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immune-oncology (I-O). A real-world study on behalf of Meet-URO group (MeetUro-7b) 33
Thermal and fluid dynamic behaviors of confined laminar impinging slot jets with nanofluids 33
Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis 33
A Prognostic Model for Patients With Metastatic Renal Cell Cancer: What's New? 33
Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy 33
Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors 33
Words of Wisdom. Re: Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy 33
Sipuleucel-T for prostate cancer: the immunotherapy era has commenced 33
A comprehensive outlook on intracerebral therapy of malignant gliomas. 33
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: A phase II study 32
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis 32
Instant messaging in cancer care 32
Real-world experience with cabazitaxel in patients with metastatic castration-resistant prostate cancer: a final, pooled analysis of the compassionate use programme and early access programme 32
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study 32
Optimal management of a patient with recurrent nasopharyngeal carcinoma 32
Prospective clinical trials of biotherapies in solid tumors: a 5-year survey 32
Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: a comparative study 32
Adrenal sparing surgery in the treatment of renal cell carcinoma: when is it possible? 32
Neuroendocrine immunophenotype as predictor of clinical recurrence in 110 patients with prostate cancer 32
Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: A multicenter study 31
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection 31
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial 31
Numerical study of laminar confined impinging slot jets with nanofluids 31
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 31
Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era 31
A Challenging Surgical Approach to Locally Advanced Primary Urethral Carcinoma: A Case Report and Literature Review 31
Chirurgia conservativa e qualità di vita in pazienti con carcinoma renale localizzato. 31
Complete response and fatigue improvement with the combined use of cyclophosphamide and quercetin in a patient with metastatic bladder cancer a case report 31
Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme? 31
READY: Real-world data from an Italian compassionate use program of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC) 31
The Role of Sipuleucel-T in Therapy for Castration-Resistant Prostate Cancer: A Critical Analysis of the Literature 31
Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer - A multi-institutional, long-term experience 31
Targeted Therapy in the Treatment of Metastatic Renal Cell Cancer 30
The use of interferon in melanoma patients: a systematic review 30
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 30
Toxicities of Targeted Therapy and Their Management in Kidney Cancer 30
Expression of HECA-452 in parapsoriasis and mycosis fungoides 30
Computed-Tomography-Structured Reporting in Middle Ear Opacification: Surgical Results and Clinical Considerations From a Large Retrospective Analysis 30
Predicting early and delayed bleedings in children who undergo adeno-tonsillectomy surgery. Is it really possible? 30
KIDNEY CANCER Overall survival is an unsuitable primary end point 30
Sipuleucel-T (Provenge®) for castration-resistant prostate cancer 30
Bio-inspired method for advanced industrial sludge treatment with closed cycle drying process 30
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer 29
Testicular cancer from diagnosis to epigenetic factors 29
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial 29
PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study 29
New perspectives in the therapy of castration resistant prostate cancer 29
Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma 29
Totale 4.113
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.664
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.165 0 0 0 28 338 19 114 372 101 60 553 580
2025/20267.822 266 27 355 434 922 444 687 408 2.064 1.118 603 494
2026/2027152 152 0 0 0 0 0 0 0 0 0 0 0
Totale 10.139